Teprotumumab

ATC L04AG13 · 9 markets · 10 records

Teprotumumab 9 markets · 10 records Forms

AU 2 records · 2 strengths

  • 500 mginjectionTEPEZZA teprotumumab 500 mg injection powder vial also in US·GB unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 1 records · 1 strengths

GB 1 records · 1 strengths

  • 500 mginjectionTepezza 500mg powder for concentrate for solution for infusion vials also in AU·US

CA 1 records · 1 strengths

SG 1 records · 1 strengths

  • 500 mg/vialinjectionTEPEZZA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG/VIAL

TW 1 records · 1 strengths

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名TEPEZZA for injection ×1適目達注射劑 ×1

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    HK 1 records · 1 strengths

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
      With a brand name Con nombre comercial 有商品名 有商品名TEPEZZA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG ×1

      Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.